CFTR and cystic fibrosis: Although future studies are needed to validate the impact on ΔF508-CFTR in CF-HBE cells, developing agents selectively inhibiting RFFL-mediated CFTR ubiquitination may help improve the efficacy of CF pharmacological therapy.